Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12565981rdf:typepubmed:Citationlld:pubmed
pubmed-article:12565981lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C1516985lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C0024883lld:lifeskim
pubmed-article:12565981lifeskim:mentionsumls-concept:C0039286lld:lifeskim
pubmed-article:12565981pubmed:issue3lld:pubmed
pubmed-article:12565981pubmed:dateCreated2003-2-4lld:pubmed
pubmed-article:12565981pubmed:abstractTextWe have examined the outcome of older patients with operable breast cancer treated in a randomised trial by either standard surgery or less extensive surgery and tamoxifen. There were 236 participants aged >/=70 years, randomised to either modified radical mastectomy MRM (n=120) or wide local excision (WLE) and tamoxifen (T) 20 mg daily (n=116). Survival curves were estimated using the Kaplan-Meier method and multivariate analyses were performed using Cox's proportional hazards model. Endpoints were survival and time to first relapse or progression, loco-regional progression, time to distant progression and progression-free survival. No significant difference was seen in terms of progression-free survival, but there were significantly more loco-regional relapses in the WLE+T group. In contrast, there were more distant metastases in the MRM group, but with a similar overall survival in both groups. The results of this trial give cautious support for the use of WLE+T for selected older women.lld:pubmed
pubmed-article:12565981pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:languageenglld:pubmed
pubmed-article:12565981pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:citationSubsetIMlld:pubmed
pubmed-article:12565981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565981pubmed:statusMEDLINElld:pubmed
pubmed-article:12565981pubmed:monthFeblld:pubmed
pubmed-article:12565981pubmed:issn0959-8049lld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:LegrandCClld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:MargreiterRRlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:FentimanI SISlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:ChaudaryM AMAlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:TherassePPlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:KarydasIIlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:van ZijlJJlld:pubmed
pubmed-article:12565981pubmed:authorpubmed-author:EORTClld:pubmed
pubmed-article:12565981pubmed:issnTypePrintlld:pubmed
pubmed-article:12565981pubmed:volume39lld:pubmed
pubmed-article:12565981pubmed:ownerNLMlld:pubmed
pubmed-article:12565981pubmed:authorsCompleteYlld:pubmed
pubmed-article:12565981pubmed:pagination300-8lld:pubmed
pubmed-article:12565981pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:meshHeadingpubmed-meshheading:12565981...lld:pubmed
pubmed-article:12565981pubmed:year2003lld:pubmed
pubmed-article:12565981pubmed:articleTitleTreatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.lld:pubmed
pubmed-article:12565981pubmed:affiliationHedley Atkins Breast Unit, Guy's Hospital, SE1 9RT, London, UK. ian.fentiman@cancer.org.uklld:pubmed
pubmed-article:12565981pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12565981pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12565981pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12565981pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12565981pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12565981lld:pubmed